Publication | Closed Access

A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression

VaccinationGroup B StrainVaccine DevelopmentVaccine TargetOpca ExpressionImmunologyPhase 1MicrobiologyInfection ControlVaccine DesignMedicineVaccine ResearchClinical Microbiology